Fig. 3From: IVIVC assessment, pharmacokinetic evaluation, and X-ray radiography mapping of Novel Parteck® SRP 80 and hypromellose-loaded LTD4 receptor antagonist chronosystemPlasma concentration vs the time profile of commercially available formulation and newly created MTS ChrDDS. The developed chronosystem showed a sustained release of the drug up to 24 hBack to article page